交易 Jaguar Health, Inc. - JAGX CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
交易条件
| 价差 | - | ||||||||
|
多头隔夜费
Long position overnight fee
前往平台 | -0.024068% | ||||||||
|
空头隔夜费
Short position overnight fee
前往平台 | 0.001846% | ||||||||
| 隔夜费时间 | 21:00 (UTC) | ||||||||
| 最小交易量 | 1 | ||||||||
| 货币 | USD | ||||||||
| 保证金 | 20% | ||||||||
| 上市交易所 | United States of America | ||||||||
| 交易费 | 0% |
*Information provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | 平倉 | Change | Change (%) | 開倉 | High | Low |
|---|
Jaguar Health, Inc. Events
| 時間（協調世界時） (UTC) | 國家 | 事件 |
|---|---|---|
| No events scheduled | ||
- 年度
- 每季度
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| 总收入 | 4.335 | 9.385 | 5.77526 | 4.41615 | 4.36119 |
| 收入 | 4.335 | 9.385 | 5.77526 | 4.41615 | 4.36119 |
| 收入成本，共计 | 2.333 | 3.28 | 3.81581 | 2.76575 | 0.88041 |
| 毛利 | 2.002 | 6.105 | 1.95945 | 1.6504 | 3.48078 |
| 总营业费用 | 45.796 | 37.896 | 39.6643 | 34.5802 | 39.0853 |
| 销售/一般/行政费用，总计 | 25.997 | 20.996 | 20.4389 | 22.1088 | 14.3314 |
| 研究与开发 | 15.079 | 6.413 | 5.81982 | 5.15475 | 4.26946 |
| 异常费用（收入） | 2.387 | 7.207 | 9.58971 | 4.55093 | 19.604 |
| 营业收入 | -41.461 | -28.511 | -33.889 | -30.1641 | -34.7241 |
| 利息收入（费用），非经营净值 | -10.374 | -5.488 | -4.72125 | -2.29767 | -0.51429 |
| 其他，净值 | -0.765 | 0.19 | 0.08083 | 0.31569 | 0.08855 |
| 税前净收入 | -52.6 | -33.809 | -38.5294 | -32.1461 | -35.1499 |
| 税后净收入 | -52.6 | -33.809 | -38.5394 | -32.1461 | -21.9686 |
| 未计算非常项目前的净收益 | -52.595 | -33.809 | -38.5394 | -32.1461 | -21.9686 |
| 净收入 | -52.595 | -33.809 | -38.5394 | -32.1461 | -21.9686 |
| Total Adjustments to Net Income | 0 | -4.839 | -6.18681 | ||
| 普通股股东可获收益 (不含非经常性项目) | -52.595 | -38.648 | -44.7262 | -32.1461 | -21.9686 |
| 普通股股东可获收益 (含非經常性項目) | -52.595 | -38.648 | -44.7262 | -32.1461 | -21.9686 |
| 摊薄净收入 | -52.595 | -38.648 | -44.7262 | -32.1461 | -21.9686 |
| 摊薄后加权平均股 | 0.59601 | 0.1717 | 0.02206 | 0.00093 | 0.01287 |
| 扣除特别项目的每股摊薄盈利 | -88.2458 | -225.09 | -2027.26 | -34495.6 | -1707.42 |
| Dividends per Share - Common Stock Primary Issue | |||||
| 每股正常摊薄盈利 | -84.2408 | -183.115 | -1744.73 | -29612.1 | -717.051 |
| 非常规项目总计 | 0 | ||||
| 少数股东权益 | 0.005 |
| Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | |
|---|---|---|---|---|---|
| 总收入 | 3.15 | 2.921 | 2.625 | 2.08 | 0.63 |
| 收入 | 3.15 | 2.921 | 2.625 | 2.08 | 0.63 |
| 收入成本，共计 | 0.613 | 0.456 | 0.455 | 0.469 | 0.617 |
| 毛利 | 2.537 | 2.465 | 2.17 | 1.611 | 0.013 |
| 总营业费用 | 13.046 | 9.4 | 16.566 | 12.902 | 10.159 |
| 销售/一般/行政费用，总计 | 6.493 | 6.493 | 8.979 | 6.951 | 6.23 |
| 研究与开发 | 5.94 | 2.451 | 4.945 | 5.482 | 3.312 |
| 异常费用（收入） | 0 | 0 | 2.187 | 0 | 0 |
| 营业收入 | -9.896 | -6.479 | -13.941 | -10.822 | -9.529 |
| 利息收入（费用），非经营净值 | -2.555 | -1.827 | -5.054 | -2.747 | -2.643 |
| 其他，净值 | -0.158 | -1.084 | 0.831 | -0.749 | -0.02 |
| 税前净收入 | -12.609 | -9.39 | -18.164 | -14.318 | -12.192 |
| 税后净收入 | -12.609 | -9.39 | -18.164 | -14.318 | -12.192 |
| 未计算非常项目前的净收益 | -12.52 | -9.367 | -17.986 | -14.313 | -12.192 |
| 净收入 | -12.52 | -9.367 | -17.986 | -14.313 | -12.192 |
| Total Adjustments to Net Income | 0 | 0 | |||
| 普通股股东可获收益 (不含非经常性项目) | -12.52 | -9.367 | -17.986 | -14.313 | -12.192 |
| 普通股股东可获收益 (含非經常性項目) | -12.52 | -9.367 | -17.986 | -14.313 | -12.192 |
| 摊薄净收入 | -12.52 | -9.367 | -17.986 | -14.313 | -12.192 |
| 摊薄后加权平均股 | 1.41781 | 1.06239 | 0.99178 | 0.61775 | 0.61105 |
| 扣除特别项目的每股摊薄盈利 | -8.83053 | -8.81695 | -18.1351 | -23.1696 | -19.9525 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| 每股正常摊薄盈利 | -8.83053 | -8.81695 | -15.9299 | -23.1696 | -19.9525 |
| 少数股东权益 | 0.089 | 0.023 | 0.178 | 0.005 |
- 年度
- 每季度
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| 流动资产总额 | 28.434 | 17.792 | 9.52235 | 8.14994 | 3.7991 |
| 现金和短期投资 | 17.051 | 8.09 | 3.49543 | 2.56819 | 0.5207 |
| 现金等价物 | 0.5207 | ||||
| 应收账款总额，净额 | 2.144 | 4.56 | 1.69458 | 1.0018 | 0.46904 |
| Accounts Receivable - Trade, Net | 1.709 | 4.532 | 1.69171 | 0.99568 | 0.46766 |
| Total Inventory | 4.9 | 2.782 | 2.12869 | 3.34218 | 2.07282 |
| Prepaid Expenses | 4.339 | 2.36 | 1.26274 | 1.23777 | 0.49737 |
| Other Current Assets, Total | 0 | 0.94091 | 0 | 0.23917 | |
| Total Assets | 53.265 | 42.843 | 36.4104 | 41.042 | 43.6292 |
| Property/Plant/Equipment, Total - Net | 1.734 | 0.677 | 0.71021 | 0.76062 | 1.22207 |
| Other Long Term Assets, Total | 0.446 | 0.037 | 0.15397 | 0.42083 | 0 |
| Total Current Liabilities | 15.471 | 13.22 | 15.3924 | 26.6588 | 15.3858 |
| Accounts Payable | 4.929 | 4.759 | 5.35154 | 5.41426 | 7.35493 |
| Accrued Expenses | 7.357 | 4.493 | 3.2589 | 4.93944 | 2.19955 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 4.84558 | 1.14115 |
| Current Port. of LT Debt/Capital Leases | 3.184 | 3.789 | 6.77846 | 11.2392 | 4.28146 |
| Other Current Liabilities, Total | 0.001 | 0.179 | 0.00349 | 0.22038 | 0.40867 |
| Total Liabilities | 41.654 | 25.641 | 15.8424 | 26.6588 | 26.3682 |
| Total Long Term Debt | 25.022 | 12.421 | 0.45 | 0 | 10.9824 |
| Long Term Debt | 25.022 | 12.421 | 0.45 | 0 | 10.9824 |
| Other Liabilities, Total | 0.919 | 0 | |||
| Total Equity | 11.611 | 17.202 | 20.568 | 14.3831 | 17.261 |
| Redeemable Preferred Stock | 0 | 0 | 11.6065 | 9 | 0 |
| Common Stock | 0.005 | 0.011 | 0.00546 | 0.00649 | 0.01053 |
| Additional Paid-In Capital | 231.1 | 184.09 | 142.046 | 99.9274 | 79.6552 |
| Retained Earnings (Accumulated Deficit) | -219.494 | -166.899 | -133.09 | -94.5508 | -62.4047 |
| Total Liabilities & Shareholders’ Equity | 53.265 | 42.843 | 36.4104 | 41.042 | 43.6292 |
| Total Common Shares Outstanding | 50.4733 | 40.1279 | 45.0589 | 40.4184 | 42.6378 |
| Goodwill, Net | 0 | 5.21082 | |||
| Intangibles, Net | 22.651 | 24.337 | 26.0239 | 31.7106 | 33.3972 |
| Cash | 17.051 | 8.09 | 3.49543 | 2.56819 | |
| Property/Plant/Equipment, Total - Gross | 2.032 | 0.942 | 0.93428 | ||
| Accumulated Depreciation, Total | -0.298 | -0.265 | -0.22407 | ||
| Total Preferred Shares Outstanding | 0 | 0 | 5.53706 | ||
| Minority Interest | 0.242 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| 流动资产总额 | 28.474 | 28.434 | 24.005 | 44.294 | 44.104 |
| 现金和短期投资 | 17.456 | 17.051 | 12.375 | 21.992 | 32.25 |
| Cash | 17.456 | 17.051 | 12.375 | 21.992 | 32.25 |
| 应收账款总额，净额 | 2.255 | 2.144 | 2.205 | 4.174 | 5.927 |
| Accounts Receivable - Trade, Net | 1.795 | 1.709 | 2.111 | 4.134 | 5.897 |
| Total Inventory | 4.879 | 4.9 | 4.513 | 3.402 | 2.821 |
| Prepaid Expenses | 3.884 | 4.339 | 4.912 | 4.806 | 3.106 |
| Other Current Assets, Total | 9.92 | 0 | |||
| Total Assets | 52.906 | 53.265 | 59.255 | 69.539 | 68.713 |
| Property/Plant/Equipment, Total - Net | 1.757 | 1.734 | 1.7 | 1.751 | 0.674 |
| Property/Plant/Equipment, Total - Gross | 2.18 | 2.032 | 1.99 | 2.033 | 0.948 |
| Accumulated Depreciation, Total | -0.423 | -0.298 | -0.29 | -0.282 | -0.274 |
| Intangibles, Net | 22.229 | 22.651 | 23.072 | 23.494 | 23.916 |
| Other Long Term Assets, Total | 0.446 | 0.446 | 10.478 | 0 | 0.019 |
| Total Current Liabilities | 19.093 | 15.471 | 11.951 | 12.652 | 12.592 |
| Accounts Payable | 3.708 | 4.929 | 3.786 | 4.918 | 4.74 |
| Accrued Expenses | 8.494 | 7.357 | 6.381 | 6.582 | 6.409 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 6.89 | 3.184 | 1.781 | 1.145 | 1.431 |
| Other Current Liabilities, Total | 0.001 | 0.001 | 0.003 | 0.007 | 0.012 |
| Total Liabilities | 44.861 | 41.654 | 37.703 | 37.754 | 36.822 |
| Total Long Term Debt | 24.783 | 25.022 | 24.926 | 24.195 | 24.23 |
| Long Term Debt | 24.783 | 25.022 | 24.926 | 24.195 | 24.23 |
| Total Equity | 8.045 | 11.611 | 21.552 | 31.785 | 31.891 |
| Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 0.008 | 0.005 | 0.005 | 0.014 | 0.013 |
| Additional Paid-In Capital | 245.517 | 231.1 | 226.728 | 224.76 | 210.786 |
| Retained Earnings (Accumulated Deficit) | -237.48 | -219.494 | -205.181 | -192.989 | -178.908 |
| Total Liabilities & Shareholders’ Equity | 52.906 | 53.265 | 59.255 | 69.539 | 68.713 |
| Total Common Shares Outstanding | 79.1948 | 50.4733 | 48.2117 | 47.8944 | 44.7563 |
| Total Preferred Shares Outstanding | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities, Total | 0.921 | 0.919 | 0.826 | 0.907 | |
| Minority Interest | 0.064 | 0.242 |
- 年度
- 每季度
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| 净收入/起跑线 | -52.6 | -33.809 | -38.5394 | -32.1461 | -21.9686 |
| 经营活动产生的现金 | -34.97 | -15.278 | -20.4568 | -22.7308 | -9.82494 |
| 经营活动产生的现金 | 1.719 | 1.727 | 1.73708 | 1.319 | 0.58434 |
| 非现金物品 | 13.644 | 20.271 | 17.0073 | 9.02132 | 20.6123 |
| 已付现金利息 | 0.028 | 0.757 | 0.142 | 0.01934 | 0.23455 |
| 营运资金的变化 | 2.267 | -3.467 | -0.66177 | -0.9251 | 4.12831 |
| 投资活动产生的现金 | -0.006 | -0.007 | 0 | -0.00653 | -1.55734 |
| 资本支出 | -0.006 | -0.007 | -0.00653 | 0 | |
| 其他投资现金流量项目，总计 | 0 | 0 | -1.55734 | ||
| 融资活动产生的现金 | 43.937 | 19.492 | 21.772 | 24.5457 | 10.6799 |
| 融资现金流项目 | -0.731 | -1.008 | -2.57481 | -2.11755 | 0 |
| 股票的发行（报废），净额 | 35.615 | 7.756 | 24.4468 | 25.8797 | 10.302 |
| 债务的发行（退还），净额 | 9.053 | 12.744 | -0.1 | 0.78349 | 0.37791 |
| 现金净变化 | 8.961 | 4.207 | 1.31519 | 1.80832 | -0.70241 |
| Deferred Taxes | 0 | -13.1812 |
| Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -18.164 | -52.6 | -38.282 | -26.09 | -12.009 |
| Cash From Operating Activities | -7.695 | -34.97 | -26.047 | -16.615 | -6.708 |
| Cash From Operating Activities | 0.426 | 1.719 | 1.29 | 0.861 | 0.431 |
| Non-Cash Items | 7.583 | 13.644 | 10.601 | 7.609 | 4.695 |
| Cash Interest Paid | 0.011 | 0.028 | 0.021 | 0.008 | 0.006 |
| Changes in Working Capital | 2.46 | 2.267 | 0.344 | 1.005 | 0.175 |
| Cash From Investing Activities | -0.006 | -10.484 | -0.006 | 0 | |
| Capital Expenditures | -0.006 | -0.006 | -0.006 | 0 | |
| Cash From Financing Activities | 8.15 | 43.937 | 40.816 | 40.443 | 30.868 |
| Financing Cash Flow Items | -0.335 | -0.731 | -0.623 | -0.268 | -0.095 |
| Issuance (Retirement) of Stock, Net | 9.11 | 35.615 | 32.386 | 31.608 | 21.86 |
| Issuance (Retirement) of Debt, Net | -0.625 | 9.053 | 9.053 | 9.103 | 9.103 |
| Net Change in Cash | 0.405 | 8.961 | 4.285 | 23.822 | 24.16 |
| Other Investing Cash Flow Items, Total | -10.478 | ||||
| Foreign Exchange Effects | -0.05 |
交易計算器
如果您在特定日期（选择一个日期）开立差价合约交易并在不同日期（选择一个日期）关闭交易，计算您的假设盈亏。
貿易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模（槓桿 x 投資）：
開倉
平倉
做空 做多
Jaguar Health, Inc. Company profile
关于 Jaguar Health Inc
Jaguar Health, Inc.是一家处于商业阶段的制药公司。 公司致力于开发以植物为基础的、非阿片类的、可持续提取的处方药，用于治疗人们和动物的胃肠道（GI）不适，包括慢性和衰弱性腹泻。 公司通过两个部门运营：人类健康和动物健康。 动物健康部门专注于开发和商业化用于伴侣动物和生产动物的处方和非处方产品。 其Canalevia-CA1用于治疗狗的化疗引起的腹泻。 人类健康部门专注于人类产品的开发和商业化，以及正在进行的Mytesi的商业化，该产品用于人类免疫缺陷病毒（HIV）/获得性免疫缺陷综合症（AIDS）成人患者在抗逆转录病毒治疗中的非感染性腹泻的症状缓解。 其全资子公司是Napo Pharmaceuticals, Inc.
| Industry: | Bio Therapeutic Drugs |
200 Pine Street Suite 400
SAN FRANCISCO
CALIFORNIA 94104
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗？
加入成为全球500,000万多名交易者的一份子，选择利用Capital.com进行交易吧。